ConductScience.org, home

Paper365072

Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.

van Rossum J and 4 others. Ann Neurol, 1977. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial. Papers, record 365072. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/365072

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.
PubMed
Journal
Ann Neurol
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
2.16
iCite
Revised in PubMed
2016-11-23
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van Rossum JJ
2Wintzen ARA R
3Endtz LJL J
4Schoen JHJ H
5de Jonge HH

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cyclohexanecarboxylic AcidsMajor topic
Subarachnoid HemorrhageMajor topic
Tranexamic AcidMajor topic
Aged
Cerebral Angiography
Clinical Trials as Topic
Double-Blind Method
Humans
Intracranial Aneurysm
Middle Aged
Prognosis
Recurrence

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
42095754
European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage.
Eur Stroke J2026https://conductscience.org/library/papers/42095754PubMed
40599738Efficacy and safety of tranexamic acid administration for subarachnoid hemorrhage: a systematic review and meta-analysis.Front Neurol2025https://conductscience.org/library/papers/40599738PubMed
40316838Relationship between Tranexamic Acid Use and Safety in Patients with Acute Brain Injury: A Systematic Review and Meta-analysis of Mortality and Thromboembolic Events.CNS Drugs2025https://conductscience.org/library/papers/40316838PubMed
37228855The efficacy of antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.Future Sci OA2023https://conductscience.org/library/papers/37228855PubMed
36350005Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/36350005PubMed
35140671Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.Front Neurol2021https://conductscience.org/library/papers/35140671PubMed
35083272Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Front Surg2021https://conductscience.org/library/papers/35083272PubMed
34677620Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine.Intensive Care Med2021https://conductscience.org/library/papers/34677620PubMed
34315966Tranexamic acid in non-traumatic intracranial bleeding: a systematic review and meta-analysis.Sci Rep2021https://conductscience.org/library/papers/34315966PubMed
23990381Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/23990381PubMed
21761274Rebleeding after aneurysmal subarachnoid hemorrhage.Neurocrit Care2011https://conductscience.org/library/papers/21761274PubMed
18386187Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.Neurocrit Care2008https://conductscience.org/library/papers/18386187PubMed
10400410Tranexamic acid: a review of its use in surgery and other indications.Drugs1999https://conductscience.org/library/papers/10400410PubMed
9854979Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage.J Neurol Neurosurg Psychiatry1998https://conductscience.org/library/papers/9854979PubMed
7435290Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid.Acta Neurochir (Wien)1980https://conductscience.org/library/papers/7435290PubMed
7376944Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid.Acta Neurochir (Wien)1980https://conductscience.org/library/papers/7376944PubMed
7282453Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.Acta Neurochir (Wien)1981https://conductscience.org/library/papers/7282453PubMed
7229645Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm.J Neurol Neurosurg Psychiatry1981https://conductscience.org/library/papers/7229645PubMed
7131009Ruptured intracranial aneurysms: has the incidence of early rebleeding been over-estimated?J Neurol Neurosurg Psychiatry1982https://conductscience.org/library/papers/7131009PubMed
7048863Antifibrinolytic treatment in subarachnoid haemorrhage: present state.Acta Neurochir (Wien)1982https://conductscience.org/library/papers/7048863PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/365072

GET https://conductscience.org/api/papers/v1/365072/cited_by?page=2